Skip to main content

Table 2 Primary outcome (modified Rankin Scale score at 6 months) and secondary outcomes

From: Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan

 

ITT

TXA group

Standard care group

OR (95% CI)

aOR (95% CI)

mRS 0–3

XX

XX

XX (XX–XX)

XX (XX–XX)

Mortality at 30 days

XX

XX

XX (XX–XX)

XX (XX–XX)

Mortality at 6 mo

XX

XX

XX (XX–XX)

XX (XX–XX)

  1. aOR adjusted odds ratio, CI confidence interval, ITT intention to treat, mRS modified Rankin Scale, OR odds ratio, TXA tranexamic acid
Back to article page

Trials

ISSN: 1745-6215